By Fineline Cube China’s National Healthcare Security Administration (NHSA), jointly with the National Development and Reform Commission and National Health Commission, issued comprehensive “Guidance on Promoting the Development of Grassroots Medical and Health Services with Medical Insurance Support”, deploying 14 structural reforms to redirect medical insurance fund flows toward primary care and township‑level institutions.
Policy Milestone
| Item | Detail |
|---|---|
| Issuing Agencies | NHSA, NDRC, National Health Commission (tripartite coordination) |
| Policy Document | Guidance on Promoting Grassroots Medical Development via Medical Insurance Support |
| Key Mechanism | Regional pilot program – ~15 selected contact point regions |
| Implementation Scope | National framework with localized adaptation |
| Settlement Target | Complete prior‑year fund settlement by end‑March annually from 2028 |
Reform Architecture – 8 Strategic Pillars
1. Fund Flow Rebalancing
- Regional Total Management Optimization: Newly added medical insurance funds tilted toward grassroots levels
- Medical Consortium Surplus Distribution: Primary‑level institutions prioritized in surplus allocation
- Target: Reverse historical concentration of funds in tertiary hospitals
2. Provider Network Expansion
- Designated Institution Coverage: Eligible grassroots providers promptly included in medical insurance network
- Medical Assistance Mandate: At least one township/sub‑district level grassroots institution per medical assistance designated area
3. Benefit Structure Enhancement
| Policy Layer | Minimum Reimbursement Ratio | Strategic Intent |
|---|---|---|
| Employee Medical Insurance (outpatient) | ≥ 50% | Incentivize primary‑care utilization |
| Resident Medical Insurance (outpatient pooling) | ≥ 50% | Reduce tertiary hospital congestion |
| Chronic Disease Management | Long‑prescription authority for eligible patients | Care continuity at grassroots level |
- Differential Hospitalization Benefits: Widened reimbursement gaps between institution tiers to favor grassroots admissions
- Deductible Optimization: Reasonable threshold setting for township‑level hospitalization
4. Pricing & Service Mix Optimization
- Consultation Fee Benchmark: General consultation fee standardized at ~RMB10 (~US$1.40)
- Expanded Service Portfolio:
- Home service fees
- Hospice care fees
- Family bed establishment fees
- Internet consultation/follow‑up fees
- Traditional Chinese medicine and rehabilitation services
5. Payment Reform & Family Doctor Integration
- Service Package Refinement: Basic + personalized family doctor contracting tiers
- Payment Innovation:
- Outpatient capitation payment linked to chronic disease management
- Per‑capita outpatient fund allocation to grassroots institutions or family doctor teams
- DRG Consolidation: Improved inpatient diagnosis‑related group payment quality with dynamic grouping adjustments
6. Fund Settlement Efficiency
- Prepayment Policy: Expanded medical insurance fund prepayment coverage
- Real‑Time Settlement Expansion: Reduced provider cash‑flow pressure
- Three‑Year Action Plan: 2028 target for March completion of prior‑year settlements
7. Drug Supply Chain Modernization
- “Three‑Tier” Drug Linkage: Standardized prescription circulation and demand matching within medical consortia
- Medical Insurance Drug Cloud Platform: Accelerated construction for centralized procurement integration
- Chronic Disease Focus: Expanded centralized procurement coverage for common disease medications at grassroots level
8. Digital Infrastructure & Service Convenience
- Facial Recognition Payment: Accelerated deployment at grassroots institutions
- 24‑Hour Intelligent Services: Online intelligent consultation for medical insurance queries in enabled regions
Market Impact & Outlook
- Primary Care Investment Signal: The 14‑point Guidance represents the most comprehensive grassroots healthcare financing reform since China’s 2009 medical insurance expansion, signaling structural capital reallocation from tertiary to primary care infrastructure.
- Medical Consortium Economics: Surplus distribution rules favoring grassroots levels may accelerate consolidation trends, with township hospitals and community health centers gaining negotiating leverage within regional consortium structures.
- Pharmaceutical Distribution Shift: “Three‑tier” drug linkage and cloud platform development favor centralized procurement scale players and logistics providers with grassroots reach; chronic disease medication volumes at primary care expected to increase 20‑30% annually.
- Digital Health Integration: Facial recognition payment and internet consultation fee recognition legitimize telemedicine reimbursement at grassroots level, creating regulatory tailwinds for health tech platforms with primary‑care connectivity.
- Regional Pilot Risk: ~15 contact point regions will test implementation viability; successful models expected for national rollout by 2028‑2030, with potential resistance from tertiary hospital networks facing revenue dilution.
Forward‑Looking Statements
This brief contains forward‑looking statements regarding policy implementation timelines, fund flow redistribution, and market impact projections. Actual results may differ due to regional execution variability, institutional resistance, and fiscal constraint dynamics.-Fineline Info & Tech